Skip to content

Cerebral Mechanism of Tuina Analgesia in Management of Knee Osteoarthritis using multimodal MRI: a Randomized Controlled Trial

Cerebral Mechanism of Tuina Analgesia in Management of Knee Osteoarthritis using multimodal MRI: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037966
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of ACR for knee arthritis in 1991; 2. Patients aged between 40 and 60 years with right hand and left knee pain; 3. Whether the I-II X-ray changes of knee joint conform to Kellgren Lawrence scale; 4. Patients with average knee pain score >=3 (range from 0 to 10) in the past three months; 5. Patients who voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have taken analgesics or anesthetics that may affect the results of brain imaging in the past month; 2. Patients who have received other treatment in the past month; 3. Pregnant women or lactating women; 4. Patients with chronic pain symptoms such as mental disease, nervous system disease, infectious disease, gastrointestinal disease, cardiovascular disease, immune system disease, respiratory system disease or kidney disease, or history of brain injury and loss of consciousness; 5. Patients diagnosed with cancer, tuberculosis, rheumatism or rheumatoid arthritis, gout and joint trauma; 6. Patients with claustrophobia, pacemaker, defibrillator, cardiac stent, intrauterine device and other contraindications of MRI; 7. Patients with skin injury around the knee joint.

Design outcomes

Primary

MeasureTime frame
The Visual Analog Scale (VAS);fMRI - functional connectivity (FC);structure - gray matter density, cortical thickness, subcortical nuclei volumes;diffusion - FA and MD of white matter integrity;

Secondary

MeasureTime frame
Short-form McGill Pain Questionnaire (SF-MPQ);Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC);the 36-Item Short Form Health Survey (SF-36);Hamilton Depression Scale (HAMD);the Hamilton Anxiety Scale (HAMA);

Countries

China

Contacts

Public ContactZhu Qingguang

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine

zhuqingguang@126.com+86 13671739891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026